Strata Skin Sciences EBITDA Margin 2010-2025 | SSKN
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Strata Skin Sciences (SSKN) over the last 10 years. The current EBITDA margin for Strata Skin Sciences as of June 30, 2025 is .
| Strata Skin Sciences EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-06-30 | $0.03B | $-0.01B | -14.71% |
| 2025-03-31 | $0.03B | $0.00B | -8.82% |
| 2024-12-31 | $0.03B | $0.00B | -11.76% |
| 2024-09-30 | $0.03B | $0.00B | -9.09% |
| 2024-06-30 | $0.03B | $0.00B | -6.06% |
| 2024-03-31 | $0.03B | $0.00B | -9.09% |
| 2023-12-31 | $0.03B | $0.00B | -5.88% |
| 2023-09-30 | $0.04B | $0.00B | 5.56% |
| 2023-06-30 | $0.04B | $0.00B | 5.56% |
| 2023-03-31 | $0.04B | $0.00B | 5.41% |
| 2022-12-31 | $0.04B | $0.00B | 5.56% |
| 2022-09-30 | $0.03B | $0.00B | 2.94% |
| 2022-06-30 | $0.03B | $0.00B | 3.03% |
| 2022-03-31 | $0.03B | $0.00B | 3.23% |
| 2021-12-31 | $0.03B | $0.00B | 3.33% |
| 2021-09-30 | $0.03B | $0.00B | 3.57% |
| 2021-06-30 | $0.03B | 0 | 0.00% |
| 2021-03-31 | $0.02B | $0.00B | -4.35% |
| 2020-12-31 | $0.02B | 0 | 0.00% |
| 2020-09-30 | $0.03B | 0 | 0.00% |
| 2020-06-30 | $0.03B | 0 | 0.00% |
| 2020-03-31 | $0.03B | $0.00B | 3.23% |
| 2019-12-31 | $0.03B | $0.00B | 3.23% |
| 2019-09-30 | $0.03B | $0.00B | 3.33% |
| 2019-06-30 | $0.03B | $0.00B | 6.45% |
| 2019-03-31 | $0.03B | $0.00B | 6.67% |
| 2018-12-31 | $0.03B | $0.00B | 6.67% |
| 2018-09-30 | $0.03B | 0 | 0.00% |
| 2018-06-30 | $0.03B | $0.00B | 3.33% |
| 2018-03-31 | $0.03B | $0.00B | 12.90% |
| 2017-12-31 | $0.03B | $0.01B | 19.35% |
| 2017-09-30 | $0.03B | $0.01B | 33.33% |
| 2017-06-30 | $0.03B | $0.01B | 32.26% |
| 2017-03-31 | $0.03B | $0.01B | 25.81% |
| 2016-12-31 | $0.03B | $0.01B | 18.75% |
| 2016-09-30 | $0.03B | $0.00B | 12.12% |
| 2016-06-30 | $0.03B | $0.01B | 18.18% |
| 2016-03-31 | $0.03B | $0.00B | -11.54% |
| 2015-12-31 | $0.02B | $0.00B | -22.22% |
| 2015-09-30 | $0.01B | $-0.01B | -77.78% |
| 2015-06-30 | $0.00B | $-0.01B | -1400.00% |
| 2015-03-31 | $0.00B | $-0.01B | 0.00% |
| 2014-12-31 | $0.00B | $-0.01B | 0.00% |
| 2014-09-30 | $0.00B | $-0.02B | 0.00% |
| 2014-06-30 | $0.00B | $-0.02B | 0.00% |
| 2014-03-31 | $0.00B | $-0.02B | 0.00% |
| 2013-12-31 | $0.00B | $-0.02B | 0.00% |
| 2013-09-30 | $0.00B | $-0.02B | 0.00% |
| 2013-06-30 | $0.00B | $-0.02B | 0.00% |
| 2013-03-31 | $0.00B | $-0.02B | 0.00% |
| 2012-12-31 | $0.00B | $-0.02B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.010B | $0.034B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.991B | 53.84 |
| Tempus AI (TEM) | United States | $13.179B | 0.00 |
| Doximity (DOCS) | United States | $12.725B | 56.62 |
| Hims & Hers Health (HIMS) | United States | $9.572B | 78.43 |
| IRhythm Technologies (IRTC) | United States | $5.461B | 0.00 |
| Hinge Health (HNGE) | United States | $4.399B | 0.00 |
| Privia Health (PRVA) | United States | $2.828B | 209.46 |
| Inspire Medical Systems (INSP) | United States | $2.771B | 40.74 |
| Heartflow (HTFL) | $2.557B | 0.00 | |
| Phreesia (PHR) | United States | $1.884B | 0.00 |
| Enovis (ENOV) | United States | $1.766B | 9.34 |
| 10x Genomics (TXG) | United States | $1.744B | 0.00 |
| Omnicell (OMCL) | United States | $1.497B | 28.84 |
| Schrodinger (SDGR) | United States | $1.436B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 61.08 |
| Clover Health Investments (CLOV) | United States | $1.343B | 0.00 |
| Claritev (CTEV) | United States | $1.135B | 0.00 |
| Evolent Health (EVH) | United States | $1.134B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.679B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.652B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.481B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 133.00 |
| Butterfly Network (BFLY) | United States | $0.405B | 0.00 |
| Carlsmed (CARL) | United States | $0.354B | 0.00 |
| TruBridge (TBRG) | United States | $0.300B | 52.53 |
| Outset Medical (OM) | United States | $0.247B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.239B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.234B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.213B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.195B | 0.00 |
| CapsoVision (CV) | United States | $0.175B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.168B | 0.00 |
| CareCloud (CCLD) | United States | $0.163B | 7.38 |
| American Well (AMWL) | United States | $0.111B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.077B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| Pulmonx (LUNG) | United States | $0.070B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| 111 (YI) | China | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.046B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Precipio (PRPO) | United States | $0.025B | 0.00 |
| PROFUSA (PFSA) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |